Delivery Order SPE2DB20D1110-SPE2DB25FK40E
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,084.59 to AmerisourceBergen Drug Corp for the supply of Losartan Potassium 25 mg tablets in quantities of 1,000 units. This order, which was competitively awarded without a set-aside designation, represents a firm fixed-price delivery under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The product will be delivered to AmerisourceBergen's Conshohocken, Pennsylvania location, with an...
- The Defense Logistics Agency awarded a delivery order valued at $2,182.31 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Losartan Potassium 100 mg. This non-set-aside, competitively awarded contract features firm fixed pricing and was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction...
- The Defense Logistics Agency awarded a delivery order valued at $1,080.19 to AmerisourceBergen Drug Corp for the supply of Losartan Potassium 50 mg tablets in quantities of 1,000 units. This contract represents a firm fixed price delivery order with an ultimate completion date of August 14, 2025, and was competitively awarded without set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,414.81 to AmerisourceBergen Drug Corp for the supply of Losartan Potassium 100 mg tablets in quantities of 1,000 units. This award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on open competition. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Losartan Potassium 50 mg tablets in quantities of 1,000 units, with a contract ceiling value of $1,151.65. This is a firm fixed price delivery order with an ultimate completion date of August 21, 2025. The award was not set-aside and represents a competitively awarded transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Losartan Potassium 100 mg tablets in quantities of 1,000 units, with a ceiling value of $1,663.10. This firm fixed-price delivery order is set to be completed by July 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was awarded competitively without set-aside provisions, reflecting AmerisourceBergen's capability to meet...
- The Defense Logistics Agency awarded a delivery order valued at $1,011.75 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of 1,000 tablets of Losartan Potassium 50 mg. This contract represents a firm fixed price delivery order with no set-aside designation, competitively awarded through open procurement. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 22, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Losartan Potassium 50 mg tablets in quantities of 1,000 units. This competitively awarded, firm fixed-price contract carries a ceiling value of $1,090.04 and is scheduled for completion by August 1, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999.99...
- The Defense Logistics Agency awarded a $4,855.20 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of 1,000 tablets of Losartan Potassium 100 mg. The contract utilizes firm fixed pricing under a non-set-aside, competitively awarded arrangement, with an ultimate completion date of August 5, 2025. Performance will occur at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order worth $1,495.76, is for the supply of 4,566,599 units of Losartan Potassium 100 mg tablets. The contract has an ultimate completion date of December 4, 2024 and is a Firm Fixed Price agreement. It is not designated as a set-aside contract. AmerisourceBergen holds a significant...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB25FK40EDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,509.04 to AmerisourceBergen Drug Corp for the supply of Losartan Potassium 100 mg tablets in quantities of 1,000 units. This non-competitive delivery order carries a firm fixed price arrangement and is scheduled for completion by September 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same municipality. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of medications and medical supplies to military healthcare systems. Losartan Potassium, a common antihypertensive medication, represents a routine pharmaceutical commodity within the Defense Health Agency's medical supply requirements, consistent with AmerisourceBergen's established role as a critical vendor for federal military and veteran healthcare procurement across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 9/10/25 |